Tech Company Financing Transactions
NantBioscience Funding Round
On 6/3/2015, NantBioscience secured $10 million in Seed funding from private investors.
Transaction Overview
Company Name
Announced On
6/3/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9920 Jefferson Blvd.
Culver City, CA 90232
USA
Culver City, CA 90232
USA
Phone
Email Address
Not Recorded
Overview
NantBioScience, a NantWorks company, is a biopharmaceutical company focused on the discovery of medicines designed to target the root cause of cancer growth and spread. Dr. Patrick Soon-Shiong, the creator of Abraxane® and the founder of the nano albumin-bound (nab®) technology platform, established NantBioScience in 2011.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Soon-Shiong
Browse more venture capital transactions:
Prev: 6/2/2015: Payfirma venture capital transaction
Next: 6/3/2015: Layer3 TV venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs